Petra Pharma
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
450 E 29th St Ste 506, New York, New Yor...Phone Number
(646) 440-9210Website
www.petrapharmacorp.comRevenue
$5.5 MillionIndustry
About Petra Pharma
Petra, a clinical-stage pharmaceutical company, is a leader in phosphoinositide (PI) signaling pathway inhibition for the treatment of cancer and other serious diseases. PI signaling pathways play a central role in a variety of important cellular processes, including cell division, growth, trafficking and signaling, and impacting human health. Petra was founded in 2016 to advance the cutting-edge research of Dr. Lewis Cantley from Weill Cornell Medical Center and Dr. Nathanael Gray from Harvard Medical School and Dana-Farber Cancer Institute.Explore more
SIC Code 28,283NAICS Code 32,325Show morePetra Pharma Org Chart
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Petra Pharma
Sign Up For FreeTo access detailed company insights
Petra, a clinical-stage pharmaceutical company, is a leader in phosphoinositide (PI) signaling pathway inhibition for the treatment of cancer and other serious diseases. PI signaling pathways play a central role in a variety of important cellular processes, including cell division, growth, trafficking and signaling, and impacting human health. Petr... Read More